Colorectal Cancer Trends of 2018 in Romania-an Important Geographical Variation Between Northern and Southern Lands and High Mortality Versus European Averages.
Colorectal cancer
Geographical variation
Hospitalized morbidity
Mortality
Romania
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
pubmed:
11
3
2020
medline:
8
6
2021
entrez:
11
3
2020
Statut:
ppublish
Résumé
In Romania, one of the highest rates for colorectal cancer (CRC) incidence and mortality in Europe was estimated based on data available in 2008. Ever since, consistent data are missing. In this article, we tried to estimate the general burden of CRC in our country. We collected data from all hospitalized recorded cases according to the ICD-10 revision (codes C18-C20), as both primary and secondary diagnoses, as reported by all the hospitals to the DRG National System, between 2016 and 2018. There were 50,890 persons hospitalized with CRC. The prevalence of hospitalized colorectal cancer was 108.24/100,000 inhabitants in 2016, 113.09/100,000 inhabitants in 2017, and 116.83/100,000 inhabitants in 2018. Distal localization prevailed. We registered 34.13/100,000 deaths by CRC within the mentioned period of time, almost twofold higher than average European range. There are significant geographical differences regarding CRC prevalence and mortality, with higher rates in the Northern and Central Regions, and a very low prevalence and mortality in Bucharest and Southern provinces. We note a high colorectal mortality rate in Romania, especially in the Northern and Central Regions, nearly double versus European ranges.
Identifiants
pubmed: 32152824
doi: 10.1007/s12029-020-00382-3
pii: 10.1007/s12029-020-00382-3
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
222-228Références
Ferlay J, Ervik M, et al. GLOBOCAN 2012, vo1.2 Cancer Incidence and Mortality Worldwide: IARC CancerBase 11, 2015.
Altobelli E, Lattanzi A, Paduano R. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med. 2014;62:132–41.
doi: 10.1016/j.ypmed.2014.02.010
Bray F, Sankila R. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99–166.
doi: 10.1016/S0959-8049(01)00350-1
Segnan N, Von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis - first edition: Publications Office of the European Union; 2010.
Altobelli E, Rapacchietta L. Differences in colorectal cancer surveillance epidemiology and screening in the WHO European Region. Oncol Lett. 2019;17:2531–42.
pubmed: 30675315
Ferlay J, Colombet M. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.
doi: 10.1016/j.ejca.2018.07.005
Ferlay J, Colombet M, Soerjomataram I. Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer/World Health Organization, 2018.
Johnson CM, Wei C. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207–22.
doi: 10.1007/s10552-013-0201-5
Hewitson P, Glasziou P, Watson E. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–9.
doi: 10.1111/j.1572-0241.2008.01875.x
Scholefield JH, Moss SM, Mangham CM. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2012;61:1036–40.
doi: 10.1136/gutjnl-2011-300774
Shaukat A, Mongin SJ, Geisser MS. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–14.
doi: 10.1056/NEJMoa1300720
Benard F, Barkun AN, Martel M. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24:124–38.
doi: 10.3748/wjg.v24.i1.124
Schreuders EH, Ruco A, Rabeneck L. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49.
doi: 10.1136/gutjnl-2014-309086
Colorectal cancer statistics. World Cancer Research Fund https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics , accessed February 2019.
Bosetti C, Bertuccio P, Malvezzi M. Cancer mortality in Europe, 2005-2009 and overview of trends since 1980. Ann Oncol. 2013;24:2657–71.
doi: 10.1093/annonc/mdt301
Torre LA, Bray F. Global cancer statistics 2012. CA Cancer J Clin. 2015;65:87–108.
doi: 10.3322/caac.21262
Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. WJG. 2017;23:5086–96.
doi: 10.3748/wjg.v23.i28.5086
Key Statistics for Colorectal Cancer - American Cancer Society https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html , accessed February 2019.
Center MM, Jemal A, Smith RA. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366.
doi: 10.3322/caac.20038
Center M, Jemal A. International trends in colorectal cancer incidence rates. CancerEpidemiol Biomarkers Prev. 2009;18:1688–94.
doi: 10.1158/1055-9965.EPI-09-0090
Turati F, Bravi F, Di Maso M. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and colorectal cancer risk. Eur J Cancer. 2017;85:86–94.
doi: 10.1016/j.ejca.2017.08.015
Cancer statistics – specific cancers. EUROSTAT. Statistics Explained http://ec.europa.eu/eurostat/statisticsexplained , accessed October 2018.
Bosetti C, Levi F, Rosato V. Recent trends in colorectal cancer mortality in Europe. Int J Cancer. 2011;129:180–91.
doi: 10.1002/ijc.25653
Smittenaar CR, Petersen KA, Stewart K. Cancer incidence and mortality projections in the UK until 2035. Brit J Cancer. 2016;115:1147–55.
doi: 10.1038/bjc.2016.304
Doubeni CA, Laiyemo AO, Major JM. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2012;118:3636.
doi: 10.1002/cncr.26677
Willett WC. Diet and cancer: an evolving picture. JAMA. 2005;293:233.
doi: 10.1001/jama.293.2.233
Doubeni CA, Major JM, Laiyemo AO. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst. 2012;104:1353.
doi: 10.1093/jnci/djs346
Klabunde CN, Cronin KA, Breen N. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomark Prev. 2011;20:1611.
doi: 10.1158/1055-9965.EPI-11-0220
Colorectal Cancer: Risk factors and prevention. https://www.cancer.net/cancer-types/colorectal-cancer/risk-factors-and-prevention. ASCO.org
Colon and Rectal Cancer Statistics & Risk Factors .Colorectal Cancer https://www.ccalliance.org/colorectal-cancer-information/statistics-risk-factors
Rabeneck L, Davila JA, El-Serag HB. Is there a true “shift” to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003;98:1400–9.
pubmed: 12818288
Mensink PB, Kolkman JJ, Van Baarlen J. Change in anatomic distribution and incidence of colorectal carcinoma over a period of 15 years: clinical considerations. Dis Colon Rectum. 2002;45:1393–6.
doi: 10.1007/s10350-004-6431-6
Ikeda Y, Akagi K, Kinoshita J. Different distribution of Dukes’ stage between proximal and distal colorectal cancer. Hepatogastroenterology. 2002;49:1535–7.
pubmed: 12397728
Wong R. Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med. 2010;25:1157–63.
doi: 10.1007/s11606-010-1460-4
McCallion K, Mitchell RM, Wilson RH. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut. 2001;48:522–5.
doi: 10.1136/gut.48.4.522